These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7428118)

  • 1. Quantum chemical studies of anaerobic reductive metabolism of halothane by cytochrome P-450.
    Goldblum A; Loew GH
    Chem Biol Interact; 1980 Oct; 32(1-2):83-99. PubMed ID: 7428118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans.
    Chow T; Imaoka S; Hiroi T; Funae Y
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes.
    Kawamoto M; Fujii K; Yuge O; Morio M
    Hiroshima J Med Sci; 1989 Dec; 38(4):161-7. PubMed ID: 2637243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ
    Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the reductive metabolism of halothane by microsomal cytochrome b5 in rat liver.
    Tamura S; Kawata S; Sugiyama T; Tarui S
    Biochim Biophys Acta; 1987 Dec; 926(3):231-8. PubMed ID: 3689822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes.
    Fujii K
    Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A spin trap study on anaerobic dehalogenation of halothane by a reconstituted liver microsomal cytochrome P-450 enzyme system.
    Fujii K; Miki N; Kanashiro M; Miura R; Sugiyama T; Morio M; Yamano T; Miyake Y
    J Biochem; 1982 Jan; 91(1):415-8. PubMed ID: 6279588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    Gruenke LD; Konopka K; Koop DR; Waskell LA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reductive metabolism of halogenated alkanes by liver microsomal cytochrome P450.
    Nastainczyk W; Ahr HJ; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):391-6. PubMed ID: 7073766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive metabolism of halothane by purified cytochrome P-450.
    Van Dyke RA; Baker MT; Jansson I; Schenkman J
    Biochem Pharmacol; 1988 Jun; 37(12):2357-61. PubMed ID: 3390202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the formation of chlorotrifluoroethane and chlorodifluoroethylene from halothane.
    Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR; Lind RC
    Anesthesiology; 1981 May; 54(5):383-9. PubMed ID: 7224207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6).
    Minoda Y; Kharasch ED
    Anesthesiology; 2001 Aug; 95(2):509-14. PubMed ID: 11506127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbene generation by cytochromes and electronic structure of heme-iron-porphyrin-carbene complex: a quantum chemical study.
    Taxak N; Patel B; Bharatam PV
    Inorg Chem; 2013 May; 52(9):5097-109. PubMed ID: 23560646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P-450 and halothane metabolism. Decrease in rat liver microsomal P-450 in vitro.
    Krieter PA; van Dyke RA
    Chem Biol Interact; 1983 Jun; 44(3):219-35. PubMed ID: 6872091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
    Trudell JR; Bösterling B; Trevor AJ
    Mol Pharmacol; 1982 May; 21(3):710-7. PubMed ID: 7110119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.